699810P

PHAD^™-504

Avanti Research^™ - A Croda Brand

• Synonyme(s) : Monophosphoryl Lipid A-504
• Formule empirique (notation de Hill): C₉₄H₁₈₀ N₃O₂₂P
• Numéro CAS: 1332714-01-8
• Poids moléculaire : 1735.42
• Code UNSPSC : 12352211
• Nomenclature NACRES : NA.25

Propriétés

• Pureté: >99% (HPLC)
• Forme: powder
• Conditionnement: pkg of 1 × 1 mg (699810P-1mg); pkg of 1 × 5 mg (699810P-5mg)
• Fabricant/nom de marque: Avanti Research^™ - A Croda Brand
• Application(s): vaccine development
• Conditions d'expédition: dry ice
• Température de stockage: −20°C

Description

Description générale

PHAD^™-504 was designed as a synthetic structural analog of detoxified monophosphoryl lipid A (MPLA) derived from E. coli lipopolysaccharide (LPS). It is structurally similar to PHAD^™, differing only in the length of a single fatty acid chain. As expected, the activity of PHAD^™-504 is quite similar to that of PHAD^™, making the two products interchangeable as adjuvants in vaccine or immunotherapy formulations.

Conditionnement

2 mL Amber Glass Crimp Cap Vial (699810P-1mg)

2 mL Amber Glass Crimp Cap Vial (699810P-5mg)

Autres remarques

For R&D use only. Not for drug, household, or other uses.

Informations légales

Avanti Research is a trademark of Avanti Polar Lipids, LLC

PHAD is a trademark of Avanti Polar Lipids, LLC

Informations sur la sécurité

• Code de la classe de stockage: 11 - Combustible Solids
• Classe de danger pour l'eau (WGK): WGK 3
• Point d'éclair (°F): No data available
• Point d'éclair (°C): No data available